Literature DB >> 11519893

Creatinine excretion rates for renal clearance studies.

S Hellerstein1, S D Simon, M Berenbom, P Erwin, E Nickell.   

Abstract

A total of 637 timed-urine collections for creatinine excretion rates obtained from 295 children over 14 years have been analyzed. The children ranged in age from 2.8 to 21.7 years at the time of the clearance study. The data analyzed included only one study from a child during any 6-month period. The objective is to provide data defining the expected range of creatinine excretion for renal clearance studies. One hundred forty-two studies were conducted on children not pretreated with cimetidine and 495 on those pretreated with cimetidine. Analysis showed that pretreatment with cimetidine for creatinine clearance studies does not alter creatinine excretion rates (P=0.080; 95% CI -0.03 to 1.61). Creatinine excretion rates in urine collections obtained at home (roughly 24-h collections) were compared with 2-h supervised collections in the Children's Kidney Center. The supervised urine collections resulted in creatinine excretion rates 1.38 mg/kg/24 h greater than home collections (P=0.001; 95% CI 0.76-2.00). Using regression equations for creatinine excretion rate with age, tables have been prepared showing the expected rate of creatinine excretion for renal clearance studies in children 3-21 years of age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519893     DOI: 10.1007/s004670100622

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Comparison of two formulae for estimation of glomerular filtration rate in children.

Authors:  Stanley Hellerstein; Max Berenbom; Sylvia DiMaggio; Pat Erwin; Stephen D Simon; Nancy Wilson
Journal:  Pediatr Nephrol       Date:  2004-04-08       Impact factor: 3.714

2.  Spot urine protein to creatinine ratio.

Authors:  Guido Filler; Shih-Han Susan Huang
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

3.  Clinical utility of spot urine protein-to-creatinine ratio modified by estimated daily creatinine excretion in children.

Authors:  Eun Mi Yang; Bo Ae Yoon; Soo Wan Kim; Chan Jong Kim
Journal:  Pediatr Nephrol       Date:  2017-02-10       Impact factor: 3.714

4.  Timed-urine collections for renal clearance studies.

Authors:  Stanley Hellerstein; Max Berenbom; Pat Erwin; Nancy Wilson; Sylvia DiMaggio
Journal:  Pediatr Nephrol       Date:  2005-10-28       Impact factor: 3.714

5.  Longitudinal study of bone mineral density in children with idiopathic hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares; Mariana Campos Linhares; Ana Carolina Silva Barbosa; Maarmed Cunha
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

6.  Interpretation of the Fractional Excretion of Sodium in the Absence of Acute Kidney Injury: A Cross-Sectional Study.

Authors:  Michiel F Schreuder; Arend Bökenkamp; Joanna A E van Wijk
Journal:  Nephron       Date:  2017-04-08       Impact factor: 2.847

7.  The ratio of urinary cystatin C to urinary creatinine for detecting decreased GFR.

Authors:  Stanley Hellerstein; Max Berenbom; Pat Erwin; Nancy Wilson; Sylvia DiMaggio
Journal:  Pediatr Nephrol       Date:  2004-03-10       Impact factor: 3.714

8.  American and Brazilian Children With Primary Urolithiasis: Similarities and Disparities.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares; Milena Maria Moreira Guimarães; Tarak Srivastava; Uri Saggie Alon
Journal:  Glob Pediatr Health       Date:  2014-11-28

9.  Role of FGF23 in Pediatric Hypercalciuria.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares; Uri Saggie Alon
Journal:  Biomed Res Int       Date:  2017-12-31       Impact factor: 3.411

10.  Association between dietary pattern and metabolic disorders in children and adolescents with urolithiasis.

Authors:  Mariana S Vieira; Priscila de C Francisco; Ana Luiza L C Hallal; Maria Goretti M G Penido; Nilzete L Bresolin
Journal:  J Pediatr (Rio J)       Date:  2019-02-05       Impact factor: 2.990

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.